Abstract: This review summarizes comorbidity measurements used on patients with nontraumatic brain injury in inpatient rehabilitation and describes findings on measurement validation and comorbidity profiles. MEDLINE and MEDLINE In-Process, EMBASE, PsycINFO, the Cochrane Database of Systematic Reviews, Health, and Psychosocial Measurement Instruments were searched. Two reviewers screened results according to predefined inclusion and exclusion criteria. Population, statistical methods, comorbidity measurement, justification of its use, and results involving comorbidity were extracted using a standard table. Of 9476 articles retrieved, 16 were included. Comorbidity has been measured using various methods including the following: number and type within various classification systems, such as the International Disease Classification system, the Charlson comorbidity index, Centers for Medicare and Medicaid Services comorbidity tiers and patient comorbidity and complexity level values and subsets of diagnoses within nonadministrative data studies. No studies have assessed the predictive ability of the comorbidity measurements for inpatient rehabilitation outcomes in this population. Because comorbidities are common among the nontraumatic brain injury population, the predictive validity of comorbidity measurements should be assessed to determine the most appropriate measure to predict or risk adjust rehabilitation outcomes, which has implications for the development of clinical guidelines, and to inform health service research, planning, and delivery.
A cquired nontraumatic brain injury (nTBI) is defined as an insult to the brain that affects its structure or function, resulting in impairments of cognition, communication, physical function, or psychosocial behavior, which is caused by tumors, infectious diseases, hypoxic injuries, metabolic disorders, and toxic exposure-excluding conditions that are congenital, degenerative, or induced by birth trauma.
1 Nontraumatic brain injury is at least as common as TBI. 2 However, the cost of treatment for patients with nTBI is three times higher than the cost of treatment for patients with TBI, with the costs of inpatient rehabilitation amounting to approximately one third of the total costs for the 10% of patients with nTBI who are discharged to inpatient rehabilitation. 3 Given the significant costs of inpatient rehabilitation, it is important to understand the factors associated with inpatient rehabilitation outcomes for these patients. Assessment of comorbidity-a distinct clinical condition that exists or may occur during a patient's clinical course 4 -is particularly important because the presence of comorbid health conditions can affect healthcare outcomes [5] [6] [7] [8] [9] and the prevalence of individuals with comorbid medical conditions is increasing. 10 Evidence regarding the prevalence of comorbidity and their effect on healthcare outcomes depends on the comorbidity measurement and statistical methods employed. 11 However, comorbidity measurement is complicated by various definitions and tools. 12 For example, comorbidity data extracted from administrative databases or medical records [13] [14] [15] are often coded using standardized systems such as the International Classification of Diseases (ICD), which can be further aggregated using indices such as the Charlson comorbidity index (CCI). 16 In addition, comorbidity classification systems have been developed to predict the cost of inpatient rehabilitation care, such as the United States Center for Medicare and Medicaid (CMS) comorbidity tier system or patient comorbidity and complexity level (PCCL) values. Finally, patient classification systems have been developed that incorporate comorbidity information, such as Diagnosis Related Groups 17 and the US Inpatient Rehabilitation Facilities Case Mix Groups.
Many comorbidity measurement methods have been developed for specific outcomes, namely, cost or mortality, and specific patient populations and settings. For example, the CCI included 19 conditions that were significantly associated with 1-yr mortality in a sample of patients admitted to a medical center in New York in 1984. It was later validated in patients with breast cancer, 16 updated for use with administrative databases in Medicare lumbar spinal surgery patients and hospitalized patients, 18, 19 and recently updated with reassigned weights in a more contemporary setting. 20 Patient comorbidity and complexity levels, calculated on the basis of complication and comorbidity levels using a proprietary system developed by the Independent Hospital Pricing Authority, are used within various Diagnosis Related Groups systems, such as the Australianrefined and German Diagnosis Related Groups. 17 The CMS comorbidity tiers system was developed across all inpatient rehabilitation patients according to cost of treatment based on specific comorbidities hypothesized to increase costs, which were grouped into three tiers on the basis of the association between comorbidities and cost across rehabilitation impairment categories. 21, 22 Although the comorbidity tier system has been developed for the inpatient rehabilitation setting, it has not been validated specifically for patients with nTBI across a variety of patient-oriented rehabilitation outcomes, such as functional outcome.
Although the predictive validity of certain comorbidity indices have been synthesized for certain patient populations (e.g. mortality in patients with cancer 23 and cardiovascular disease 24 ), it has not been conducted for inpatient rehabilitation outcomes (such as length of stay or functional independence) in patients with nTBI. As such, it is not clear whether these comorbidity measures appropriately capture the effect of comorbidity on inpatient rehabilitation outcomes or how comorbidities can affect rehabilitation outcomes for patients with nTBI. Therefore, the primary objective of this systematic review is to address this research gap by surveying the literature on methods to measure comorbidity for patients with nTBI in inpatient rehabilitation. The secondary objective is to determine whether the studies assessed the predictive ability of the comorbidity measures for inpatient rehabilitation outcomes in patients with nTBI. The final objective is to summarize the profile of comorbidities and their effect on inpatient rehabilitation outcomes for patients with nTBI. The study of comorbidity and its measurement and association with outcomes can be used by clinicians to understand the profile of comorbidities in patients with nTBI in inpatient rehabilitation settings, the effect of comorbidity on rehabilitation outcomes, and may thus be used for health service delivery and planning.
METHODS
This systematic review was conducted on the basis of a previously developed and published protocol. 25 The presentation of results was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist 26 (see Checklist, Supplemental Digital Content, http:// links.lww.com/PHM/A422).
Search Strategy
The following databases were searched for relevant articles: Grey literature was searched using "Grey Matters: A Practical Search Tool for Evidence-Based Medicine." 27 Resources from national rehabilitation research groups, such as The US CMS and Canadian Institute for Health Information, were used to survey available information from health service providers. Finally, the reference lists of included articles were searched.
The search strategy combined the concepts "nTBI," "comorbidity," and "rehabilitation." Broad terms were purposely used to define nTBI to increase sensitivity, and more narrow terms were used to define specific nTBI conditions. The terms for comorbidity included risk adjustment concepts related to health services research, such as "diagnosis related groups," "case-mix," and "resource intensity weighting," because they may incorporate comorbidity information. All database results were limited to English language. A limit to human only studies was applied in MEDLINE and limits to exclude conference material (abstracts, paper, proceeding, reviews), and editorials, letters, or notes were applied in Embase (see file for search strategy, Supplemental Digital Content, http://links.lww.com/ PHM/A423, from Khuu et al., 2015 25 ).
Study Selection
Two reviewers independently assessed all titles and abstracts for inclusion using predetermined eligibility criteria in two rounds of screening. In the first round, record titles and abstracts were screened for reports that included an nTBI population in inpatient rehabilitation. When both the title and abstract lacked the required information to make a decision, possibly relevant records were included for the full-text screen. In the second round, full-text articles were reviewed to confirm measurement of comorbidity in patients with any type of nTBI within an inpatient rehabilitation setting.
Eligible study designs included cohort studies, case-control studies, randomized controlled trials, or systematic reviews. Qualitative studies, case-reports, abstracts, conference material, and editorials or commentaries were excluded because these sources of information are unlikely to present the level of detail and information required for the purposes of this systematic review. Ecological studies were excluded because they do not provide sufficient evidence for individual level effects of comorbidity on rehabilitation outcomes. Stroke was excluded from this review to reflect current research and clinical practice in rehabilitation where stroke is treated separately from other acquired nTBIs. 25 
Data Extraction
Data were extracted using a standard table. Author, publication year, purpose of study, year(s) of study, study design, location and setting, data source or type, number of patients with nTBI, and subtype(s) of nTBI were extracted to characterize the studies. To address the primary research objective, the comorbidity measurement method and statistical method used to quantify comorbidities were extracted. To address the secondary research objective, validation studies cited or validation statistics, if reported, were extracted. To address the tertiary objective, any statistics related to comorbidity were extracted, including descriptive or analytic statistics.
Quality Assessment
Critical Appraisal Skills Programme checklists 28 were used to guide the assessment of validity and reliability. Methodological quality-such as the use of appropriate statistical tests, accounting for confounding, and the study population selection method-was of particular importance because it can affect the interpretation and generalizability of results.
Analyses
Because of the heterogeneity of articles retrieved, the results are presented in a narrative synthesis. 29 The results were grouped into clusters by the region of study because health services research techniques are regionally specific and the type of data used because some measures have been developed for administrative data, whereas others have not.
RESULTS
The search results are presented in Figure 1 . The search yielded a total of 11575 records, from which 9476 records remained after duplicates were removed. Of the 9476 records, 83 met the criteria for a full-text screen, from which 16 were included for review. Data extraction results are summarized in Table 1 . Most articles (13/16) used a retrospective cohort design. Of these 13 studies, 11 used administrative data sources and 2 used medical file reviews. Of the 11 studies that used national administrative data, 5 were conducted in Canada and used the National Rehabilitation Reporting System (NRS) as the data source, 3 were conducted in the United States using the Uniform Data System for Medical Rehabilitation and CMS data, one was conducted in Italy using an electronic registry for severe acquired brain injury, one was conducted in Germany using administrative data from a single neurological rehabilitation hospital, and one was conducted in the United States using an institutional database. The remaining 3 of the 16 studies used a retrospective case series, a prospective cross-sectional, and a prospective matched case-case design. The overall quality of the articles was good according to the Critical Appraisal Skills Programme checklists. However, justification for the use various comorbidity measurements because they pertain to rehabilitation outcomes in patients with nTBI was rarely provided.
Comorbidity Measurement
Comorbidity in patients with nTBI has been measured using various methods, including number and type based on ICD, Tenth Revision, (ICD-10) or pre-2008 diagnostic health codes in the NRS, CCI based on the discharge abstract database (DAD), number or type of comorbidity based on ICD-9 Of the 16 studies that assessed a nTBI population, 7 studies stratified analyses and results by nTBI either as a whole or subtype of nTBI. Given the purpose of this systematic review, only comorbidity results from the studies that stratified by nTBI are described here, whereas the other studies [37] [38] [39] [44] [45] [46] [47] are summarized in Table 1 . Of the studies that stratified by nTBI, four were retrospective studies based on Canadian administrative health data, one was an Italian study of severe acquired brain injury, one was a retrospective chart review study from Australia, and one was a prospective matched case-case study conducted in Turkey. None of the studies compared the relative ability of various comorbidity measures to predict inpatient rehabilitation outcomes for patients with nTBI. However, one study assessed the predictive ability of one comorbidity measure for one outcome: Chen et al. (2014) 30 assessed the association of the CCI with living setting at discharge from inpatient rehabilitation and found that the association was not significant (P > 0.1).
Comorbidity Profiles
Comorbidities are common among the nTBI population, with mental health and addictions mentioned in two of the studies that looked at types of comorbidity. Three of the four Canadian administrative health data studies used the NRS for inpatient rehabilitation data and stratified by TBI versus nTBI. 3, 30, 31 The CCI, calculated from acute hospitalization data, was used as a descriptive measure, in which similar results were found across the following three studies: approximately 57% of nTBIs had a low CCI score (0-1), 30% had a moderate CCI score (2-3), and 12% had a high CCI score of (4+). 31 Colantonio et al. (2011) 2 measured the number and type of comorbidity using preadmit comorbidity fields in the NRS. Patients with nTBI had an mean (SD) of 3.9 (3.0) comorbidities, which included circulatory system (51.3%), nervous system (44.2%), mental health (32.6%), endocrine, nutritional, metabolic, and immune system (27.3%), musculoskeletal (22.8%), and genitourinary disorders (21.1%). Depressive disorders were the most common mental health condition and occurred in 34% of patients with patients. Avesani et al. (2013) 32 stratified patients with nTBI by anoxia and other conditions (which included infections and tumors) using an Italian national registry of severe acquired brain injury. Paraosteoarthropathies (POAs) and pressure sores at admission and discharge were reported. Anoxic patients had the highest rate of POA on discharge (9.03%), whereas patients in the other category had the highest rate of pressure sores on admission and discharge (45.28% and 20.75%, respectively). O'Brien and Todd (2009) 33 retrospectively studied 10 patients with hypoxic brain injury due to heroin overdose, in which previous drug use and psychiatric history were reported. In this sample, 50% were daily heroin users, 10% were regular heroin users, 20% were occasional users, and 50% had previous psychiatric histories, including suicide attempts (20%) and treatment for depression (30%). Geler-Kulcu et al. (2009) 34 performed a matched case-case study using patients with brain tumor. The presence of diabetes mellitus and coronary heart disease were noted within 24 hrs of admission to the inpatient rehabilitation program. A small proportion of these patients had diabetes mellitus (10%) and coronary heart disease (24%) comorbidities.
DISCUSSION
The objectives of this study were to determine (1) the methods used to measure comorbidity in patients with nTBI within an inpatient rehabilitation setting, (2) the predictive ability of the comorbidity measurement methods for rehabilitation outcomes, and (3) the profile of comorbidity in patients with nTBI in inpatient rehabilitation settings. The 16 studies that met inclusion criteria for this systematic review showed a large degree of heterogeneity in the method used to measure comorbidity and how the comorbidity information was used and presented.
The comorbidity measurements used across the studies were associated with the type and location of study. A common source of data was administrative health databases, which holds the potential to capture comorbidities systematically. Specifically, it has the ability to capture a large range of health conditions present at admission and/or discharge from various healthcare settings. The coding of these health conditions is also conducted using standardized classification systems (e.g., ICD), which provides a common language across regions and studies. Given the strengths of administrative data for capturing comorbid health conditions, the validity of comorbidity coding in these databases should be assessed and/ or improved. For example, coding using the comorbidity diagnosis fields in the DAD in Canada has been rated as "poor," depending on the healthcare condition, 45 and the validity of comorbidity information in the NRS is not known. 44 It has also been suggested that administrative data likely underestimate comorbidity compared with medical record reviews. 46 As such, comorbidity coding in administrative data could be improved or supplemented, for example, by incorporating information from medical records, which may be possible through various electronic medical record initiatives. 47 Finally, administrative data systems used in Rollnik and Janosch (2010), 39 40 were not further described, and the remaining studies used medical records and tracked unique and diverse sets of comorbid conditions, for which reliability and data quality are not known. Thus, it is recommended that a description of the data source be included in all research articles to enable further reading and research into the data source for various purposes, including systematic reviews.
This systematic review highlighted the lack of information on the predictive ability of comorbidity measurements currently used in nTBI research on inpatient rehabilitation outcomes. This is particularly important because these measures can influence study outcomes and interpretation. Thus, when using comorbidity indexes, authors should be cautious when choosing a comorbidity measure that is suited for their outcome of interest and, when possible, either validate the measure for their outcome of interest in their population of interest, provide a clear clinical rationale for choosing the measure, or both. These practices would help improve the validity of comorbidity measurement.
In addition to variability in data sources and methods used to measure comorbidity, there was also variability in the types of nTBI conditions included and subgroup stratification for analyses across the studies. For instance, five studies collapsed analyses and presented results across all patient groups, which were diverse and included all patients with cancer in rehabilitation, 38 all inpatient rehabilitation, 37 all neurologic rehabilitation patients, 39 all patients in states of severely altered consciousness, 42 and all patients with disorders of consciousness. 43 Furthermore, two studies included patients with nTBI in a "brain dysfunction" group, 35, 36 which also included TBI. The generalization of comorbidity profiles from studies that collapsed patients with nTBI into a larger group may not be valid. Thus, caution should be exercised when generalizing the prevalence of comorbidity and their effect on functional outcome and length of stay after inpatient rehabilitation. Consequently, the following discussion focuses on the studies that have provided estimates for nTBI as a whole or subtypes of nTBI.
Of the seven studies that reported comorbidity statistics for patients with nTBI specifically, only one used comorbidity (CCI) in a multivariable regression and it did not meet model selection criteria. 30 Profiles of comorbidity were presented in seven studies. Four studies by Colantonio et al. 2, 3, 30, 31 that stratified analyses by nTBI as a whole. Based on these studies, most patients with nTBI in inpatient rehabilitation settings are expected to have a low CCI score and a small proportion are expected to have high CCI scores. Moreover, patients with nTBI frequently experience a diversity of comorbid conditions, including mental, circulatory, nervous system, endocrine, nutritional, metabolic, immune, musculoskeletal, and genitourinary conditions. Within mental health diagnoses, with depressive disorders were the most common being the most common, followed by confusion, and then other conditions. However, it is unclear whether these results are confounded by etiology. For example, it is possible that patients with primary or secondary metastatic brain cancer may skew the CCI results of the nTBI population as a whole.
Three studies presented results for specific nTBI populations, including one study on brain tumor, 34 one study presented results for anoxia and other nTBI, which included brain infections and neoplasms, 41 and one study presented patients with hypoxic brain damage due to heroin overdose. 32 These studies show that differences by etiology may be expected given that there was a high rate of POA in anoxic patients compared with a high rate of pressure sores in patients with brain tumor or infection, prevalent drug use, and psychiatric history in patients with hypoxic brain injured patients due to heroin overdose, and the presence of diabetes and coronary heart disease in patients with brain tumor. However, in these studies, only specific medical conditions were investigated. A more comprehensive assessment of the distribution of other comorbidities would be helpful in providing a better description of comorbidity profiles in patients with specific nTBI conditions.
The results of this systematic review are in accordance with other systematic reviews on comorbidity measurements for different populations. Similar to studies of comorbidity measurements for cancer patients 23 and patients with cardiovascular diagnoses, 24 it seems that no standard exists for comorbidity measurement for patients with nTBI. However, comorbidities can affect rehabilitation outcomes. For example, based on a systematic review of comorbidities on outcomes of chronic obstructive pulmonary disease rehabilitation, comorbidities can influence pulmonary rehabilitation outcomes. 7 Comorbidity has also been shown to be an independent predictor of rehabilitation efficiency in geriatric and hip arthroplasty rehabilitation patients. 48 Furthermore, the choice of comorbidity measurement affects the results studies on rehabilitation outcomes. For example, at least one study on stroke rehabilitation outcomes showed that comorbidities are important predictors of stroke rehabilitation outcomes, and how they are classified impacts the results of statistical models used in assessing quality of care. 9 Accordingly, it has been suggested that comparisons of the predictive ability of comorbidity measurements should be specific to subsets of patients populations.
14 The study of the comparative predictive ability of various comorbidity measurements on rehabilitation outcomes within patients with nTBI is important given the similarity in prevalence and cost of rehabilitation of these patients compared with patients with traumatic brain injury. 3 Therefore, this review shows a substantial research gap that needs to be addressed.
Study Limitations
The strength of this systematic review is the sensitivity of the search strategy as a result of including proxy terms for each of the concepts. However, it is possible that relevant articles were not captured because of imperfect indexing systems of the databases searched. For example, the search strategy may have excluded articles that captured comorbidity and reported it in full text but were not mentioned in the title or abstract or indexed with keywords or controlled language. In addition, the definition of comorbidity was limited to medical conditions, and as such, related phenomena that may affect rehabilitation outcome, such as procedures or functional ability, were not investigated. Finally, because of the relatively small number of articles that were included in this review, caution should be exercised when interpreting the results because they may not be externally generalizable. We hope that more research will be conducted in this area to increase the generalizability of results.
CONCLUSIONS
To the best of the authors' knowledge, this is the first systematic review of methods that have been used to measure comorbidity in patients with nTBI in inpatient rehabilitation settings. The results of this systematic review demonstrate that a variety of comorbidity measurements are used to describe comorbidity in this population with no information on the predictive ability of the various comorbidity measurements for inpatient rehabilitation outcomes such as functional outcome and length of stay for the nTBI population. This may affect the results and interpretation of studies that describe comorbidities or their impact on rehabilitation outcomes. Moreover, there is a lack of evidence to suggest that subgroups of patients with nTBI experience similar comorbidities and that any given method of comorbidity measurement will best predict inpatient rehabilitation outcomes, which may be related to the limited number of articles that investigate nTBI or specific nTBI conditions and present comorbidity information for these conditions. Therefore, it would be informative to investigate each type of nTBI specifically and to determine comorbidity measurements that are predictive of given rehabilitation outcome for that type of nTBI.
The results of this review (and similar reviews in other patient populations, cited in this review) show that there are no standards for measuring comorbidity. Next steps would depend on the purpose of measuring and reporting comorbidity. If the purpose is to describe the distribution of comorbid medical conditions that are present during an inpatient rehabilitation episode, future research could aim to validate currently available methods for measuring comorbidity. For example, a chart abstraction study of the sensitivity and specificity of diagnosis fields in the NRS would be informative. In addition, leveraging electronic medical records for a more comprehensive picture of comorbidity, generally, would be helpful. If the purpose is to determine the association of comorbidity with inpatient rehabilitation outcomes, then future research should aim to validate specific measures or indexes of comorbidity for the nTBI population.
The ability to generalize and apply the measures of comorbidity, particularly for risk adjustment in health service research, is limited by heterogeneity in comorbidity measurement method, differences in population stratification, and differences in the statistical techniques used to relate comorbidity to rehabilitation outcomes. Estimates of comorbidity profiles by nTBI subtype and their effect of comorbidity on rehabilitation outcomes including LOS, functional outcome, and readmissions would be more informative and useful for the development of clinical training guidelines. Moreover, this information could be used to provide more accurate evidence for the various factors associated with rehabilitation outcomes, which can be used for effective and efficient planning and delivery of inpatient rehabilitation services. Therefore, future studies should explore the face and predictive validity of comorbidity measurement in relation to known or potentially important confounders, such as age and sex, and provide estimates of the prevalence of comorbidities by patient types to increase the generalizability of research outputs to specific populations.
